Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
CRM
|
Marc Benioff
Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 0.03% |
$523,000
$52.3 p/Share
|
Aug 13
2020 |
DJCO
|
Gerald L Salzman
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 999 Reduced 4.41% |
$285,714
$286.0 p/Share
|
Aug 13
2020 |
AUB
|
Michael W Clarke |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 0.44% |
$50,120
$25.06 p/Share
|
Aug 13
2020 |
OCN
|
Francois Grunenwald
Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 1,134 Reduced 100.0% |
-
|
Aug 12
2020 |
OCN
|
Francois Grunenwald
Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 1,134 Added 50.0% |
-
|
Aug 12
2020 |
BV
|
Richard Roedel |
BUY
Bona fide gift
|
Indirect | 2,232 Added 3.52% |
-
|
Aug 12
2020 |
BV
|
Richard Roedel |
SELL
Bona fide gift
|
Direct | 2,232 Reduced 7.27% |
-
|
Aug 12
2020 |
KNDI
|
Jerry Lewin
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,000 Added 5.26% |
-
|
Aug 12
2020 |
POWI
|
Steven Sharp
Director |
SELL
Bona fide gift
|
Direct | 16,668 Reduced 49.55% |
-
|
Aug 12
2020 |
KNDI
|
Henry Yu
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,000 Added 4.07% |
-
|
Aug 12
2020 |
HSIC
|
Stanley M Bergman
Chairman, CEO |
SELL
Bona fide gift
|
Direct | 1,919 Reduced 0.64% |
-
|
Aug 12
2020 |
IBM
|
John E Kelly Iii
Executive Vice President |
SELL
Bona fide gift
|
Direct | 7,133 Reduced 6.93% |
-
|
Aug 12
2020 |
HUM
|
Timothy S. Huval
Chief Administrative Officer |
SELL
Bona fide gift
|
Direct | 551 Reduced 7.37% |
-
|
Aug 12
2020 |
ORTX
|
Ra Capital Management, L.P.
Director |
BUY
Open market or private purchase
|
Indirect | 16,291 Added 0.18% |
$77,219
$4.74 p/Share
|
Aug 12
2020 |
LOGC
|
Arix Bioscience PLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 1,335 Reduced 0.05% |
$11,735
$8.79 p/Share
|
Aug 12
2020 |
CPLG
|
James R Abrahamson
Director |
BUY
Bona fide gift
|
Indirect | 1,494 Added 5.17% |
-
|
Aug 12
2020 |
CPLG
|
James R Abrahamson
Director |
SELL
Bona fide gift
|
Direct | 1,494 Reduced 100.0% |
-
|
Aug 12
2020 |
PACQ
|
Glazer Capital, LLC
> 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect | 576,834 Reduced 100.0% |
$6,114,441
$10.6 p/Share
|
Aug 12
2020 |
LKQ
|
Jacob H. Welch
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,665 Added 50.0% |
-
|
Aug 12
2020 |
INSP
|
Orbimed Advisors LLC
Director |
SELL
Open market or private sale
|
Indirect | 42,679 Reduced 18.52% |
$4,585,858
$107.45 p/Share
|
Aug 12
2020 |
LJPC
|
Tang Kevin C
Director |
BUY
Open market or private purchase
|
Indirect | 43,513 Added 0.5% |
$150,990
$3.47 p/Share
|
Aug 12
2020 |
PFXNZ
|
Fortress Investment Group LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 1,000 Reduced 0.37% |
$16,500
$16.5 p/Share
|
Aug 12
2020 |
XOMA
|
Bvf Partners L P
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 4,050 Added 0.21% |
$70,227
$17.34 p/Share
|
Aug 12
2020 |
LOACU
|
Glazer Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 210 Reduced 0.06% |
$2,260
$10.76 p/Share
|
Aug 12
2020 |
XRX
|
Icahn Carl C
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 517,148 Added 1.97% |
$8,894,946
$17.2 p/Share
|
Aug 12
2020 |
HLF
|
Icahn Carl C
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 14,722,025 Reduced 41.79% |
$717,698,719
$48.75 p/Share
|
Aug 12
2020 |
UPL
|
Fir Tree Capital Management LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 1,278,000 Reduced 4.8% |
$25,560
$0.02 p/Share
|
Aug 12
2020 |
DNLI
|
Douglas K Bratton
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 1,443,247 Reduced 10.58% |
$45,678,767
$31.65 p/Share
|
Aug 12
2020 |
DNB
|
Thomas H. Lee Advisors, LLC |
BUY
Grant, award, or other acquisition
|
Direct | 9,664 Added 66.67% |
-
|
Aug 12
2020 |
MDLZ
|
May Peter W
Director |
SELL
Open market or private sale
|
Indirect | 555,000 Reduced 4.34% |
$31,080,000
$56.0 p/Share
|
Aug 12
2020 |
FRME
|
Michael C Rechin
Director |
BUY
Grant, award, or other acquisition
|
Direct | 15,000 Added 11.77% |
$407,100
$27.14 p/Share
|
Aug 12
2020 |
FRME
|
Jeffrey B Lorentson
Chief Audit Executive |
BUY
Grant, award, or other acquisition
|
Direct | 600 Added 4.28% |
$16,284
$27.14 p/Share
|
Aug 12
2020 |
FRME
|
John Martin
Chief Credit Officer |
BUY
Grant, award, or other acquisition
|
Direct | 7,500 Added 15.31% |
$203,550
$27.14 p/Share
|
Aug 12
2020 |
FRME
|
Mark K Hardwick
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 9,500 Added 10.3% |
$257,830
$27.14 p/Share
|
Aug 12
2020 |
FRME
|
Stephan Fluhler
Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct | 4,000 Added 18.03% |
$108,560
$27.14 p/Share
|
Aug 12
2020 |
FRME
|
Michael J Stewart
President |
BUY
Grant, award, or other acquisition
|
Direct | 9,200 Added 11.49% |
$249,688
$27.14 p/Share
|
Aug 12
2020 |
FRME
|
Michele Kawiecki
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 4,000 Added 25.87% |
$108,560
$27.14 p/Share
|
Aug 12
2020 |
FRME
|
Steven C Harris
Director of Human Resources |
BUY
Grant, award, or other acquisition
|
Direct | 2,250 Added 21.32% |
$61,065
$27.14 p/Share
|
Aug 12
2020 |
TXN
|
Darla H Whitaker
Sr. Vice President |
SELL
Open market or private sale
|
Direct | 40,000 Reduced 44.68% |
$5,540,800
$138.52 p/Share
|
Aug 12
2020 |
TXN
|
Darla H Whitaker
Sr. Vice President |
BUY
Exercise of conversion of derivative security
|
Direct | 40,000 Added 30.88% |
$2,117,200
$52.93 p/Share
|
Aug 12
2020 |
TMUS
|
Matthew A. Staneff
EVP, Chief Marketing Officer |
SELL
Open market or private sale
|
Direct | 9,500 Reduced 15.02% |
$1,094,685
$115.23 p/Share
|
Aug 12
2020 |
ADBE
|
Shantanu Narayen
Chair and CEO |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.27% |
$4,426,900
$442.69 p/Share
|
Aug 12
2020 |
KO
|
Robert Edward Long
SVP & Chief Innovation Officer |
SELL
Open market or private sale
|
Direct | 37,534 Reduced 45.49% |
$1,809,514
$48.21 p/Share
|
Aug 12
2020 |
KO
|
Robert Edward Long
SVP & Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 37,534 Added 31.27% |
$1,201,088
$32.0 p/Share
|
Aug 12
2020 |
PG
|
David S Taylor
Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct | 26,960 Added 9.45% |
$2,120,674
$78.66 p/Share
|
Aug 12
2020 |
PG
|
David S Taylor
Executive Chairman |
SELL
Open market or private sale
|
Direct | 26,960 Reduced 10.43% |
$3,657,933
$135.68 p/Share
|
Aug 12
2020 |
PLXS
|
Michael V Schrock
Director |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 13.17% |
$393,500
$78.7 p/Share
|
Aug 12
2020 |
PLXS
|
Michael V Schrock
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 5,000 Added 11.64% |
$150,250
$30.05 p/Share
|
Aug 12
2020 |
SNX
|
Kevin M Murai
Director |
SELL
Open market or private sale
|
Direct | 4,600 Reduced 32.47% |
$598,368
$130.08 p/Share
|
Aug 12
2020 |
SNX
|
Kevin M Murai
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 4,600 Added 24.51% |
$216,752
$47.12 p/Share
|
Aug 12
2020 |